Expertise in
4
conditions

Alexander D. Guminski

40 Rocklands Rd, 
Wollstonecraft, NSW, AU 
Expertise in
4
conditions
40 Rocklands Rd, 
Wollstonecraft, NSW, AU 

Overview

Alexander Guminski practices practicing medicine in Wollstonecraft, Australia.

Mr. Guminski is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Basal Cell Skin Cancer, Melanoma, Merkel Cell Carcinoma, and Neuroendocrine Tumor.

He is actively involved in clinical research, co-authoring 88 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

40 Rocklands Rd, Wollstonecraft, NSW 2065, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase Ib/II Study of Combination Avelumab With Peptide Receptor Radionuclide Therapy or Conventional Fractionated Radiotherapy in Patients With Metastatic Merkel Cell Carcinoma
A Phase Ib/II Study of Combination Avelumab With Peptide Receptor Radionuclide Therapy or Conventional Fractionated Radiotherapy in Patients With Metastatic Merkel Cell Carcinoma
Enrollment Status: Active_not_recruiting
Publish Date: March 27, 2026
Intervention Type: Radiation, Drug
Study Drug: Avelumab
Study Phase: Phase 1/Phase 2
A Randomized, Double-blind, Adaptive, Phase II/III Study of GSK3359609 or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1 Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
A Randomized, Double-blind, Adaptive, Phase II/III Study of GSK3359609 or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1 Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Enrollment Status: Terminated
Publish Date: July 10, 2024
Intervention Type: Drug
Study Drugs: Feladilimab, Pembrolizumab
Study Phase: Phase 3
View 1 Less Clinical Trial

88 Total Publications

Vaccine-induced immunity is maintained in glioma patients relative to other solid tumours.
Vaccine-induced immunity is maintained in glioma patients relative to other solid tumours.
Journal: Journal of neuro-oncology
Published: September 02, 2025

Frequently Asked Questions about Alexander D. Guminski

Is Alexander D. Guminski a top-rated expert for Basal Cell Skin Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Alexander D. Guminski is classified as an Elite expert for Basal Cell Skin Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Alexander D. Guminski participate in research or clinical trials?

Yes. Alexander D. Guminski has published 88 articles and abstracts on conditions like Basal Cell Skin Cancer. You can view a list of Alexander D. Guminski's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Guminski's expertise for a condition
ConditionClose
View All 24 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile